Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle

Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) in Solid Organ Transplant Patients

(2013) R. A. Zuckerman et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pathways of Antigen Processing

(2013) Janice S. Blum et al.   Annual Review of Immunology

Priming of CD8+ T Cells against Cytomegalovirus-Encoded Antigens Is Dominated by Cross-Presentation

(2013) A. Busche et al.   JOURNAL OF IMMUNOLOGY

CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response

(2013) R. J. M. Abbott et al.   JOURNAL OF IMMUNOLOGY

EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail

(2013) B. D. Griffin et al.   JOURNAL OF IMMUNOLOGY

Innate immune responses against Epstein Barr virus infection

(2013) Obinna Chijioke et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Kinetics of Antigen Expression and Epitope Presentation during Virus Infection

(2013) Nathan P. Croft et al.   PLoS Pathogens

Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation

(2012) U. Gerdemann et al.   BLOOD

EBV Protein BNLF2a Exploits Host Tail-Anchored Protein Integration Machinery To Inhibit TAP

(2011) D. Horst et al.   JOURNAL OF IMMUNOLOGY

Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets

(2010) A. D. Hislop et al.   BLOOD

The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways

(2010) J. Zuo et al.   JOURNAL OF VIROLOGY

Cross-Presentation of a Spread-Defective MCMV Is Sufficient to Prime the Majority of Virus-Specific CD8+ T Cells

(2010) Christopher M. Snyder et al.   PLoS One

Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation

(2009) D. Horst et al.   JOURNAL OF IMMUNOLOGY

A Bridge Crosses the Active-Site Canyon of the Epstein–Barr Virus Nuclease with DNase and RNase Activities

(2009) Marlyse Buisson et al.   JOURNAL OF MOLECULAR BIOLOGY

The Epstein-Barr Virus Alkaline Exonuclease BGLF5 Serves Pleiotropic Functions in Virus Replication

(2009) R. Feederle et al.   JOURNAL OF VIROLOGY

Immune responses to Epstein–Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity

(2009) Martin Rowe et al.   MICROBES AND INFECTION

Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology

(2009) Martin Rowe et al.   SEMINARS IN CANCER BIOLOGY

T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display

(2009) Laura K. Mackay et al.   PLoS Pathogens

Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle

(2009) Nathan P. Croft et al.   PLoS Pathogens

The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output

(2009) Vey Hadinoto et al.   PLoS Pathogens